Kind H P, Handysides A, Kooh S W, Fraser D
J Pediatr. 1977 Dec;91(6):1006-10. doi: 10.1016/s0022-3476(77)80917-7.
The aims of this study were to determine the dose of vitamin D2 that maintains the serum calcium level within the normal range in hypoparathyroid and pseudohypoparathyroid children and to establish a safe and quickly acting dose for initiating therapy in symptomatic patients. The dose requirement for maintenance therapy was studied in 11 patients and initiation therapy was studied in five newly diagnosed hypocalcemic patients. The results show that (1) the maintenance requirement of vitamin D2 is proportional to body weight and averages 2,000 IU (50 microgram)/kg/day for children of all ages and with all types of hypoparathyroid disorders and the (2) in newly diagnosed symptomatic patients, carefully controlled administration of 8,000 IU (200 microgram) vitamin D2/kg/day for the first one to two weeks corrects hypocalcemia quickly and safely.
本研究的目的是确定能使甲状旁腺功能减退和假性甲状旁腺功能减退儿童血清钙水平维持在正常范围内的维生素D2剂量,并确定有症状患者起始治疗时安全且起效迅速的剂量。对11例患者进行了维持治疗所需剂量的研究,对5例新诊断的低钙血症患者进行了起始治疗的研究。结果显示:(1)维生素D2的维持需求量与体重成正比,所有年龄段及各种类型甲状旁腺功能减退症的儿童平均为2000 IU(50微克)/千克/天;(2)在新诊断的有症状患者中,在开始的1至2周内谨慎控制给予8000 IU(200微克)维生素D2/千克/天可迅速且安全地纠正低钙血症。